Session objectives.

Webinar recorded on October 7, 2020

  • Understanding the rationale for avoiding therapeutic inertia and the use of early combination therapy.
  • Identifying simplified risk categories of type 2 diabetes in the primary care setting. What really matters?
  • Treatment recommendations


Manel Mata-Cases

Researcher of the Barcelona Ciutat Research Support Unit of the Primary Healthcare Research Institute Jordi Gol (IDIAP-Jordi Gol, Barcelona, Spain)


Francesc Xavier Cos Claramunt

PCDE chairman
Associate Professor in General Practice. Universitat Autònoma de Barcelona.

  • Why early combination therapy in type 2 diabetes?

Samuel Seidu

MBChB, PGCME, MSc, MD, FRCGP, FRCP (Edin) NIHR Clinical Lecturer in Primary Care. Diabetes
Research Centre, University of Leicester.

  • Simplified risk categories in type 2 diabetes from the primary care perspective.

Stefan Jansson

Scientist at University Health Care Research Center, School of Health and Medical Sciences, Örebro University, Sweden.
General practitioner at Brickebacken Health Care Center, Örebro Sweden.

  • Consensus recommendations